Desq Long
Sign in
SEC FORM 4
$1,426,425.00

Entrada Therapeutics, Inc. (TRDA)

Sale of 192,500 shares at $7.41 per share.

Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001231919-26-001155 · filed 2026-09-09 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Entrada Therapeutics, Inc. (TRDA)." Disclosed 2026-09-09. https://desqlong.com/cards/0001231919-26-001155-2 (retrieved 2026-09-26).